FDA says it will greenlight pharmacies to fill prescriptions for abortion pill

Österreich Nachrichten Nachrichten

FDA says it will greenlight pharmacies to fill prescriptions for abortion pill
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 ABC
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

The FDA has loosened rules on access to the abortion pill mifepristone, used to end early pregnancies, allowing pharmacies to dispense the drug.

January 3, 2023, 6:35 PMMifepristone and Misoprostol, the two drugs used in a medication abortion, are seen at the Women's Reproductive Clinic in Santa Teresa, N.M.

"Despite the FDA's expert judgment, some states have restricted access to medical abortion care, so unfortunately today's announcement will not provide equal access to all people," Masingill said. "GenBioPro looks forward to working with prescribers and pharmacies to increase access to medical abortion care for all people."

FDA Commissioner Dr. Robert Califf speaks at an event celebrating hearing aids being available over the counter at a Walgreens, Oct. 19, 2022, in Washington, D.C.Still, she said, the FDA action signals an intention by the federal government to treat the drug more like other medications.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

ABC /  🏆 471. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Abortion Pills to Be Available More Widely Under New FDA RulesAbortion Pills to Be Available More Widely Under New FDA RulesBreaking: An abortion pill will be made more widely available under new FDA rules allowing brick-and-mortar pharmacies to dispense the drug for the first time
Weiterlesen »

FDA decision on experimental Alzheimer's drug expected this week | CNNFDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Weiterlesen »

Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportControversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Weiterlesen »

Sesame joins the major food allergens list, FDA saysSesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Weiterlesen »

Evaxion's stock soars after getting FDA approval for mid-stage cancer trialEvaxion's stock soars after getting FDA approval for mid-stage cancer trialU.S.-listed shares of Evaxion Biotech A/S undefined jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration...
Weiterlesen »



Render Time: 2025-03-13 13:51:34